Peter Buhler - Valneva SE CFO Member

All Insiders . France . 
Stock . Valneva SE . Stakeholders . Insider . Peter Buhler
VLA Stock  EUR 2.01  0.04  1.95%   

Insider

Peter Buhler is CFO Member of Valneva SE
Age 52
Phone33 2 28 07 37 10
Webhttps://valneva.com

Valneva SE Management Efficiency

The company has return on total asset (ROA) of (0.185) % which means that it has lost $0.185 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.8614) %, meaning that it generated substantial loss on money invested by shareholders. Valneva SE's management efficiency ratios could be used to measure how well Valneva SE manages its routine affairs as well as how well it operates its assets and liabilities.
Valneva SE has accumulated 50.73 M in total debt with debt to equity ratio (D/E) of 1.45, which is about average as compared to similar companies. Valneva SE has a current ratio of 1.21, suggesting that it may not have the ability to pay its financial obligations in time and when they become due. Debt can assist Valneva SE until it has trouble settling it off, either with new capital or with free cash flow. So, Valneva SE's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Valneva SE sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Valneva to invest in growth at high rates of return. When we think about Valneva SE's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Serge PicaudGensight Biologics SA
N/A
Dominique MDOSE Pharma SA
68
JeanPascal PharmDOSE Pharma SA
N/A
Raquel LizarragaAbivax SA
N/A
Scott JeffersGensight Biologics SA
N/A
Alain MDOSE Pharma SA
N/A
Benoit CanolleBiophytis SA
45
Brangre VasseurOSE Pharma SA
N/A
Linda MScOSE Pharma SA
56
Paul GinesteAbivax SA
N/A
FFPM MBABiophytis SA
52
Anne PascardAbivax SA
N/A
Prof CepkoGensight Biologics SA
N/A
JoseAlain MDGensight Biologics SA
N/A
Regina JehleAbivax SA
N/A
Pierre MBAAbivax SA
N/A
Pr RoskaGensight Biologics SA
N/A
Clothilde CailletGensight Biologics SA
N/A
TeylanBiophytis SA
N/A
Philippe MDAbivax SA
65
Prof EhrlichAbivax SA
N/A
Valneva SE, a specialty vaccine company, focused on the development and commercialization of prophylactic vaccines for infectious diseases with unmet needs. Valneva SE was incorporated in 1999 and is headquartered in Saint-Herblain, France. VALNEVA operates under Pharmaceuticals And Biosciences classification in France and is traded on Paris Stock Exchange. It employs 700 people. Valneva SE (VLA) is traded on Euronext Paris in France and employs 762 people.

Management Performance

Return On Equity-1.86
Return On Asset-0.18

Valneva SE Leadership Team

Elected by the shareholders, the Valneva SE's board of directors comprises two types of representatives: Valneva SE inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Valneva. The board's role is to monitor Valneva SE's management team and ensure that shareholders' interests are well served. Valneva SE's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Valneva SE's outside directors are responsible for providing unbiased perspectives on the board's policies.
Dipal Patel, Chief Board
Frederic Jacotot, Gen IP
Laetitia BachelotFontaine, VP Relations
JuanCarlos MD, Chief Board
Thomas Lingelbach, Pres Board
Gerald Strohmaier, VP Resource
Franck MBA, Chief Gen
Peter Buhler, CFO Member
Perry Celentano, Interim Officer
Joshua Drumm, VP Relations

Valneva Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Valneva SE a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity-1.86
Return On Asset-0.18
Profit Margin0.17 %
Operating Margin0.06 %
Current Valuation835.16 M
Shares Outstanding138.22 M
Shares Owned By Insiders17.56 %
Shares Owned By Institutions21.63 %
Price To Earning64.20 X
Price To Book5.66 X

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
RSIRush Street Interactive
OKTAOkta Inc
BACBank of America

Other Information on Investing in Valneva Stock

Valneva SE financial ratios help investors to determine whether Valneva Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Valneva with respect to the benefits of owning Valneva SE security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY